Recent Advances of Stem Cell Therapy for Retinitis Pigmentosa
AbstractRetinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by progressive loss of photoreceptors and eventually leads to retina degeneration and atrophy. Until now, the exact pathogenesis and etiology of this disease has not been clear, and many approaches for RP therapies have been carried out in animals and in clinical trials. In recent years, stem cell transplantation-based attempts made some progress, especially the transplantation of bone marrow-derived mesenchymal stem cells (BMSCs). This review will provide an overview of stem cell-based treatment of RP and its main problems, to provide evidence for the safety and feasibility for further clinical treatment. View Full-Text
Share & Cite This Article
He, Y.; Zhang, Y.; Liu, X.; Ghazaryan, E.; Li, Y.; Xie, J.; Su, G. Recent Advances of Stem Cell Therapy for Retinitis Pigmentosa. Int. J. Mol. Sci. 2014, 15, 14456-14474.
He Y, Zhang Y, Liu X, Ghazaryan E, Li Y, Xie J, Su G. Recent Advances of Stem Cell Therapy for Retinitis Pigmentosa. International Journal of Molecular Sciences. 2014; 15(8):14456-14474.Chicago/Turabian Style
He, Yuxi; Zhang, Yan; Liu, Xin; Ghazaryan, Emma; Li, Ying; Xie, Jianan; Su, Guanfang. 2014. "Recent Advances of Stem Cell Therapy for Retinitis Pigmentosa." Int. J. Mol. Sci. 15, no. 8: 14456-14474.